[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Stakeholder](https://github.com/mm80843/T3.5/tree/pages/docs/Stakeholder/index.md) >> Individual ID:PBN__Stakeholder_3087 

# __And healthcare organizations__

## Risk affecting this stakeholder

* [Ai in treatment may lead to over-reliance on automated systems, potentially overlooking critical patient factors and individualized treatment needs.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_3812.md)
* [Global data sharing and management may conflict with various countries’ laws and regulations, leading to legal challenges and regulatory non-compliance.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_4050.md)
* [Integration of data sources and digital technologies may lead to privacy breaches and unauthorized access to sensitive healthcare information.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_4506.md)
* [Iot technologies for data collection and analysis during the covid-19 pandemic](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_7685.md)
* [Limitations of manufacturing and supply chains for diagnostic testing.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_16426.md)
* [Relaxed budget policies may lead to a lack of financial resources for long-term public health infrastructure and preparedness, creating vulnerability to future disease outbreaks.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_17504.md)
* [Reliance on 5g for contact tracing may lead to privacy and security risks for individuals’ data.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_19050.md)
* [Use of ai in disease diagnosis may lead to misdiagnosis or false positives, potentially causing harm to patients.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_19052.md)

## Risks that can be mitigated by this stakeholder

* [Asymptomatic infections persist, leading to undetected clusters of contagious diseases.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_3813.md)
* [Barriers to vbd prevention, treatment, and control in tribal communities due to geographic, cultural, and social factors](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_3971.md)
* [Comparison of sars-cov-2 with sars-cov-1](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_4050.md)
* [Complex systems and uncertain environments can lead to unpredictable outcomes, including the propagation of contagious diseases.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_5209.md)
* [Dependence on a single ventilator design and manufacturer](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_5339.md)
* [Global emphasis on the need for rapid and sensitive detection techniques like biosensors](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_6452.md)
* [Global pandemic infectious disease](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_6592.md)
* [Global spread of covid-19 with millions infected from over 185 countries/regions.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_6920.md)
* [High mortality rates of known coronaviruses mers-cov, sars-cov](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_7008.md)
* [Impact on healthcare system](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_7010.md)
* [In-person teaching conferences, morbidity and mortality conferences, and simulation labs are being avoided due to the covid-19 pandemic, leading to a decrease in resident case volume.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_7029.md)
* [Inadequate allocation of resources towards public health infrastructure and pandemic preparedness](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_7064.md)
* [Inadequate health insurance coverage for different classes of society.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_7113.md)
* [Integration of digital technology may compromise privacy and data security.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_7234.md)
* [Interoperability challenges may arise when integrating multiple digital technologies used for covid-19 mitigation, leading to data silos and reduced efficiency.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_7696.md)
* [Lack of conclusive evidence for the effectiveness of shl oral liquid against covid-19](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_8522.md)
* [Lack of effective treatment for covid-19](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_11745.md)
* [Lack of vaccine or specific drug treatment for covid-19](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_12427.md)
* [Limited accessibility of healthcare data to a select group of users may raise concerns of data equity and inclusivity.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_12467.md)
* [Localised manufacturing impacting capacity for medical products](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_12470.md)
* [Manual selection of physiological characteristics for anomaly detection model development may lead to biased or incomplete feature sets, impacting the effectiveness of the models.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_12614.md)
* [Need to determine the distribution of infected individuals in each grid region before implementing quarantine measures.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_13322.md)
* [Potential spread of contagious diseases through proximity detection using bluetooth le for contact tracing.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_13774.md)
* [Reliance on 5g for contact tracing may lead to privacy and security risks for individuals’ data.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_13812.md)
* [Reliance on ai-based diagnosis for contagious diseases may lead to algorithmic biases and inaccurate identification](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_15519.md)
* [Shift towards less face-to-face human interactions due to the outbreak of covid-19](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_15673.md)
* [Spread of contagious diseases in supply chains](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_15683.md)
* [Spread of covid-19 due to lack of containment measures](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_15986.md)
* [Spread of the novel coronavirus](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_17057.md)
* [The american college of surgeons and government institutions recommending against the continuation of elective surgery, with most facilities minimizing participants in any operation to essential personnel only.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_17064.md)
* [The cancellation of educational activities, such as conferences and training courses, reduces opportunities for healthcare professionals to learn about new developments in disease prevention, diagnosis, and treatment.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_18579.md)
* [Transmission of covid-19 from person to person](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_19040.md)
* [Use of robotics in covid-19 response introduces new technology risks.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_19646.md)
* [Vulnerability of pharmaceutical supply chains](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_19865.md)

## This Stakeholder belongs to this Stakeholder Group

* [Health organisations](https://github.com/mm80843/T3.5/blob/pages/StakeholderGroup/PBN__StakeholderGroup_7.md)

